Farther Finance Advisors, LLC

Position in RLAY — Relay Therapeutics, Inc.

CIK 1992825 SAN FRANCISCO, CA

Position in RLAY

as of Jun 30, 2026 · filed Jul 17, 2026 Compact

Position Value

$76,991

+$34,197 QoQ

Shares Held

4,115

-4.3% QoQ

Ownership

0.002%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#204

of 256 holders

Holding Since

Dec 2023

10 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Farther Finance Advisors, LLC holds $15,699,251 across 282 Biotechnology names. RLAY ranks #34 (0.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	VRTX	Vertex Pharmaceuticals Inc / Ma	4,922	$2,444,905
2	MRNA	Moderna, Inc.	15,429	$1,080,492
3	ARWR	Arrowhead Pharmaceuticals, Inc.	12,088	$985,292
4	HALO	Halozyme Therapeutics, Inc.	11,241	$879,833
5	EXEL	Exelixis, Inc.	14,171	$771,044
6	REGN	Regeneron Pharmaceuticals, Inc.	1,075	$670,305
7	VKTX	Viking Therapeutics, Inc.	15,171	$591,820
8	BMRN	Biomarin Pharmaceutical Inc	7,871	$450,378

10 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$76,991	4,115	-4.3%	Shares	Sole	2026-07-17
2026-03-31	$42,794	4,301	+3.9%	Shares	Sole	2026-04-07
2025-12-31	$35,024	4,140	+17.3%	Shares	Sole	2026-01-23
2025-09-30	$18,426	3,530	-78.9%	Shares	Sole	2025-10-14
2025-06-30	$57,788	16,702	+8553.9%	Shares	Sole	2025-07-11
2025-03-31	$505	193	-91.6%	Shares	Sole	2025-04-14
2024-12-31	$9,422	2,287	+4.6%	Shares	Sole	2025-02-10
2024-09-30	$15,483	2,187	+8648.0%	Shares	Sole	2024-10-29
2024-03-31	$207	25	-75.0%	Shares	Sole	2024-05-14
2023-12-31	$1,101	100	—	Shares	Sole	2024-02-15
No filing history on record for this holder in this stock.